SHANNON DEL GRANDE: Open Payments
NPI 1447503412 · VILLANOVA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 37 payments from 15 companies in 2025. Trend: 2023 $955 · 2024 $915 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $136 |
| GENZYME CORPORATION | 4 | $117 |
| UCB, Inc. | 3 | $91 |
| Galderma Laboratories, L.P. | 4 | $82 |
| Janssen Biotech, Inc. | 3 | $76 |
| Botanix SB Inc | 2 | $48 |
| Incyte Corporation | 2 | $48 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| REVANCE THERAPEUTICS, INC. | 1 | $20 |
Products named: DUPIXENT, Bimzelx, RINVOQ, TREMFYA, NEMLUVIO, SOFDRA, OPZELURA, SKYRIZI.
Industry payments across PA — which companies pay providers there.
